Case Study: a multinational pharmaceutical company reduces Scope 1 emissions with CoolPlanet

Reducing Scope 1 emissions at an NYSE-listed pharmaceutical company by 78%

The multinational pharmaceutical company sought to decarbonize a key facility as part of its goal to achieve carbon zero. They engaged CoolPlanet to conduct an Opportunity Assessment and implement a comprehensive solution to reduce their Scope 1 emissions and overall energy consumption.

CoolPlanet executed numerous energy conservation measures, including upgrades to lighting, air handling units, steam systems, and the installation of a heat pump, a solar array, and a battery storage system. These interventions successfully reduced the site's Scope 1 emissions by 78% and F-gas volume by 28%, while generating 603 MWh of electricity annually and achieving 1.7 million kWh in energy savings.